Showing 15 posts of 80 posts found.


Google AI outperforms 58 dermatologists in detecting melanoma

May 30, 2018
Research and Development AI< Google, Cancer, melanoma, pharma, skin cancer

An deep learning artificial intelligence system has demonstrated its ability to outperform over 50 human dermatologists in the detection of …


Keytruda continues success with new Phase 3 data in adjuvant melanoma

April 16, 2018
Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …


Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018
Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …


Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017
Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …


Drug that induces tanning could protect against melanoma

June 16, 2017
Medical Communications, Research and Development melanoma, skin cancer, sun

People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …


No causal link between Viagra use and melanoma, study finds

May 19, 2017
Medical Communications, Research and Development melanoma, viagra

Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …


Researchers identify key trigger in melanoma progression

May 3, 2017
Research and Development melanoma

Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French National Institute …


SMC reverses decision on Opdivo in advanced skin cancer

August 8, 2016
Manufacturing and Production, Research and Development SMC, Scottish Medicines Consortium, melanoma, opdivo, skin cancer

The Scottish Medicines Consortium (SMC) has reversed an earlier decision for Bristol-Myers Squibb’s Opdivo (nivolumab) and has now approved recommended …


Amgen skin cancer drug Imlygic rejected by NICE

March 16, 2016
Research and Development Amgen, Imlygic, NICE, melanoma, skin cancer

NICE has rejected Amgen’s drug Imlygic (talimogene laherparepvec) in draft as a treatment for advanced melanoma that has spread and …


Merck says US FDA accepts its sBLA for Keytruda

March 8, 2016
Manufacturing and Production, Research and Development Merck & Co, US FDA, keytruda, melanoma

US pharma giant Merck & Co said the US Food and Drug Administration (FDA) has accepted for review a new …


BMS criticises Scottish regulator over Opdivo skin cancer ‘no’

March 7, 2016
Medical Communications, Research and Development Bristol-Myers Sqibb, NICE, SMC, melanoma, opdivo

Bristol-Myers Squibb says the Scottish Medicines Consortium’s (SMC) decision not to recommend its immunotherapy Opdivo (nivolumab) as a monotherapy for …


NICE ‘yes’ for BMS skin cancer drug Opdivo

January 22, 2016
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, NICE, melanoma, nivolumab, opdivo, skin cancer

NICE has approved Bristol-Myers Squibb’s skin cancer immunotherapy Opdivo (nivolumab) in final draft guidance as monotherapy for NHS patients in England …


European approval for Amgen cancer drug Imlygic

December 18, 2015
Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …


FDA approves Roche skin cancer combination

November 11, 2015
Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …


FDA approves Bristol-Myers Squibb’s skin cancer drug

October 29, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilumumab, melanoma

The FDA has recommended Bristol-Myers Squibb’s cancer drug Yervoy (ipilimumab) for the adjuvant treatment of patients with melanoma. The drug, …

Latest content